Document ID: chunk:federal_register_of_legislation:F2020C00213:body:0:p4
Version: federal_register_of_legislation:F2020C00213
Segment Type: other
Provision Reference: 
Character Range: 8348–11486

a pulmonary disease from the specified list at least five years before the clinical onset of malignant neoplasm of the lung; or

         (n)                working as a painter for a cumulative period of at least 5 000 hours before the clinical onset of malignant neoplasm of the lung, where the first inhalation occurred at least five years before the clinical onset of malignant neoplasm of the lung; or

         (o)                inhaling respirable crystalline silica dust in an enclosed space:
            (i)            for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the lung; and
            (ii)         at the time material containing crystalline silica was being produced, excavated, drilled, cut or ground, or used in construction, manufacturing, cleaning or blasting; and
            (iii)       where the first inhalation of respirable crystalline silica dust commenced at least five years before the clinical onset of malignant neoplasm of the lung; or

         (p)                inhaling respirable crystalline silica dust in an open environment:
            (i)            for a cumulative period of at least 3 000 hours before the clinical onset of malignant neoplasm of the lung; and
            (ii)         at the time material containing crystalline silica was being produced, excavated, drilled, cut or ground, or used in construction, manufacturing, cleaning or blasting; and
            (iii)       where the first inhalation of respirable crystalline silica dust commenced at least five years before the clinical onset of malignant neoplasm of the lung; or

         (q)                inhaling fumes, vapours or dusts of a metal or metalloid from the specified list:
            (i)            for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the lung; and
            (ii)         where the first inhalation of fumes, vapours or dusts occurred at least five years before the clinical onset of malignant neoplasm of the lung; or

         (r)                 inhaling fumes of bis(chloromethyl)ether or chloromethyl methyl ether:
            (i)            for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the lung; and
            (ii)         where the first inhalation of fumes occurred at least five years before the clinical onset of malignant neoplasm of the lung; or

         (s)                 having berylliosis at the time of the clinical onset of malignant neoplasm of the lung; or

         (t)                 smoking at least ten joint-years of cannabis, or the equivalent in other cannabis products, before the clinical onset of malignant neoplasm of the lung, where smoking commenced at least five years before the clinical onset of malignant neoplasm of the lung; or

         (u)                being exposed to arsenic as specified before the clinical onset of malignant neoplasm of the lung, where the first exposure to arsenic occurred at least ten years before the clinical onset of malignant neoplasm of the lung; or

         (v)